SK

Smita Kumari

Active Director Director DIN 09564877
DIN 09564877 First appointment Apr 2022 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2022
Shareholding value •••• Premium profile

About Smita Kumari

Data last updated:

Smita Kumari is a Director at Madind Pharma Private Limited (since 2022). The company operates in Chemicals. Madind Pharma Private Limited reported revenue of ₹12.2 Lakh (FY 2024).

DIN 09564877
Primary Designation Director
Industry Chemicals
First Appointment 07 Apr 2022
Oldest Company Age 4 yrs
Largest company Madind Pharma Private Limited · ₹12.2 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Madind Pharma Private Limited U24290BR2022PTC057345
Director07 Apr 20222022₹12.2 Lakh (FY 2024)Active

Board colleagues of Smita Kumari

NameDINCompanyDesignation
Neeraj Sah09564875Madind Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Madind Pharma Private Limited
Premium access

Shareholding and investment profile for Smita Kumari

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Smita Kumari

Smita Kumari currently holds 1 directorship: Madind Pharma Private Limited (Director, since 07 Apr 2022, revenue ₹12.2 Lakh (FY 2024)).

Smita Kumari was first appointed on 07 Apr 2022 as Director at Madind Pharma Private Limited.

The current boards of Smita Kumari's companies include Neeraj Sah (Madind Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available